Figure 4.

Percentage of total patients marking fear for adverse events linked to nasal corticosteroid spray, oral antihistamines, oral leukotriene antagonists and immunotherapy, no fear or no opinion.

Hellings et al. Clinical and Translational Allergy 2012 2:9   doi:10.1186/2045-7022-2-9
Download authors' original image